Alexis Desieno Sells 24,778 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares of the company's stock, valued at $479,223.20. This trade represents a 14.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Alexis Desieno also recently made the following trade(s):

• On Friday, January 3rd, Alexis Desieno sold 8,854 shares of Cardlytics stock. The stock was sold at an average price of $3.67, for a total transaction of $32,494.18.

Cardlytics Price Performance

CDLX traded down $0.27 during trading on Friday, hitting $2.69. 2,276,722 shares of the stock traded hands, compared to its average volume of 929,168. The business has a 50 day moving average price of $3.42 and a 200 day moving average price of $3.69. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics, Inc. has a twelve month low of $2.67 and a twelve month high of $20.52. The company has a market cap of $136.71 million, a price-to-earnings ratio of -0.44 and a beta of 1.54.

Analysts Set New Price Targets

CDLX has been the topic of a number of analyst reports. Craig Hallum raised Cardlytics from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, November 6th. Needham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Cardlytics presently has a consensus rating of "Hold" and a consensus price target of $6.92.

Hedge Funds Weigh In On Cardlytics

Institutional investors have recently modified their holdings of the business. Intech Investment Management LLC boosted its stake in Cardlytics by 31.3% in the fourth quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock valued at $72,000 after buying an additional 4,607 shares in the last quarter. Check Capital Management Inc. CA lifted its holdings in shares of Cardlytics by 10.4% in the third quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company's stock worth $162,000 after acquiring an additional 4,775 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in shares of Cardlytics by 32.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company's stock valued at $63,000 after purchasing an additional 4,796 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Cardlytics by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company's stock valued at $72,000 after purchasing an additional 5,392 shares during the last quarter. Finally, Wells Fargo & Company MN grew its holdings in shares of Cardlytics by 46.0% during the 4th quarter. Wells Fargo & Company MN now owns 21,106 shares of the company's stock valued at $78,000 after purchasing an additional 6,649 shares during the last quarter. Institutional investors and hedge funds own 68.10% of the company's stock.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.